Answers are grounded in this paper and cite their sources.
Lersivirine is a potent non-nucleoside reverse transcriptase inhibitor with exceptional mutant resilience. Here, we compare the pharmacological and pharmacokinetic profile of lersivirine with its pyrazole and imidazole isomers and briefly explore the profile of these series. This work establishes lersivirine as the outstanding molecule in this set.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: